Trials / Completed
CompletedNCT03104088
Studying Cognition in SPG4
Studying Cognition in SPG4 Compared to Healthy Controls
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Comparing the cognitive levels of patients with SPG4 mutations to healthy controls.
Detailed description
Comparing the cognitive levels of patients with SPG4 mutations to healthy controls by using the CANTAB® and MoCA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | CANTAB | CANTAB Cognitive Assessment (tablet based cognitive testing from CAMCOG) |
| DIAGNOSTIC_TEST | MOCA | Montreal cognitive assessment (MOCA) in German |
Timeline
- Start date
- 2017-05-10
- Primary completion
- 2017-12-24
- Completion
- 2017-12-24
- First posted
- 2017-04-07
- Last updated
- 2020-08-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03104088. Inclusion in this directory is not an endorsement.